BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan Z, Xing A, Zheng J, Li W. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma. International Journal of Hyperthermia 2019;36:159-67. [DOI: 10.1080/02656736.2018.1542510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tsoumakidou G, Mandralis K, Hocquelet A, Duran R, Denys A. Salvage Lymph-Node Percutaneous Cryoablation: Safety Profile and Oncologic Outcomes. Cardiovasc Intervent Radiol 2020;43:264-72. [DOI: 10.1007/s00270-019-02341-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J. Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. J Hepatocell Carcinoma 2021;8:625-44. [PMID: 34189133 DOI: 10.2147/JHC.S298709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Filippiadis D, Charalampopoulos G, Tsochatzis A, Reppas L, Mazioti A, Kelekis A, Kelekis N. Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center's experience. Br J Radiol 2021;94:20200445. [PMID: 33756082 DOI: 10.1259/bjr.20200445] [Reference Citation Analysis]
4 Parvinian A, Schmitz JJ, Welch BT, Atwell TD, Morris JM, Woodrum DA, Kurup AN. A Single-Institution Experience in Percutaneous Image-Guided Cryoablation of Lymph Node Metastases. AJR Am J Roentgenol 2021;217:152-6. [PMID: 33852333 DOI: 10.2214/AJR.20.22861] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen X, Lu Y, Shi X, Han G, Zhao J, Gao Y, Wang X. Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma. Front Oncol 2022;12:835957. [DOI: 10.3389/fonc.2022.835957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]